News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Veeva Systems, Inc. Files Registration Statement For Proposed Follow-On Offering


3/18/2014 7:09:10 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Veeva Systems Files Registration Statement for Proposed Follow-on Offering

PLEASANTON, Calif.--(BUSINESS WIRE)--Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the life sciences industry, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed public offering of shares of its Class A common stock. A portion of the shares to be sold in the offering will be sold by Veeva Systems, and a portion of the shares will be sold by existing stockholders of the company. Veeva Systems will not receive any proceeds from the shares sold by existing stockholders. The number of shares to be sold and the allocation of the shares between Veeva Systems and existing stockholders have not yet been determined.

Morgan Stanley & Co. LLC, Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC will act as joint book-running managers for the offering. Pacific Crest Securities LLC, Canaccord Genuity Inc., Stifel, Nicolaus & Company, Incorporated and Wells Fargo Securities, LLC will act as co-managers.

A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. Copies of the preliminary prospectus related to the offering may be obtained, when available, from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; from Deutsche Bank Securities Inc., Attention: Prospectus Department, 60 Wall Street, New York, New York 10005-2836, or via telephone at (800) 503-4611, or email at prospectus.cpdg@db.com; or from J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or via telephone at (866) 803-9204.

Contacts

Veeva Systems Inc.
Media Contact:
Jeff Seedman, 310-330-6994
pr@veeva.com
or
Investor Relations Contact:
Rick Lund, 925-271-9816
ir@veeva.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES